Abstract
Background: Vascular calcification contributes to cardiovascular disease in hemodialysis (HD) patients with diabetes. The randomized controlled trial reported here compared the effects of lanthanum carbonate (LC) and calcium carbonate (CC) on vascular stiffness assessed using brachial-ankle pulse wave velocity (ba-PWV), intima-media thickness (IMT), bone mineral density (BMD), and serum markers of chronic kidney disease – mineral and bone disorder in such patients. Methods: Ba-PWV, IMT, BMD, and the biomarkers osteocalcin (OC) and bone alkaline phosphatase (BAP) were examined in 43 type 2 diabetes HD patients treated with LC (n=21) or CC (n=22) for 2 years. Results: Forty-one patients completed the study (19, LC; 22, CC). The mean ba-PWV significantly increased only in the CC group (median: 2,280.5 to 2,402.5 cm/s, P
| Original language | English |
|---|---|
| Pages (from-to) | 111-118 |
| Number of pages | 8 |
| Journal | International Journal of Nephrology and Renovascular Disease |
| Volume | 8 |
| DOIs | |
| Publication status | Published - Aug 26 2015 |
Fingerprint
Keywords
- Diabetes
- Hemodialysis
- Lanthanum carbonate
- Randomized controlled trial
- Vascular stiffness
ASJC Scopus subject areas
- Nephrology
Cite this
Effects of lanthanum carbonate versus calcium carbonate on vascular stiffness and bone mineral metabolism in hemodialysis patients with type 2 diabetes mellitus : A randomized controlled trial. / Wada, Kentaro; Wada, Yuko; Uchida, Haruhito Adam; Tsuruoka, Shuichi.
In: International Journal of Nephrology and Renovascular Disease, Vol. 8, 26.08.2015, p. 111-118.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effects of lanthanum carbonate versus calcium carbonate on vascular stiffness and bone mineral metabolism in hemodialysis patients with type 2 diabetes mellitus
T2 - A randomized controlled trial
AU - Wada, Kentaro
AU - Wada, Yuko
AU - Uchida, Haruhito Adam
AU - Tsuruoka, Shuichi
PY - 2015/8/26
Y1 - 2015/8/26
N2 - Background: Vascular calcification contributes to cardiovascular disease in hemodialysis (HD) patients with diabetes. The randomized controlled trial reported here compared the effects of lanthanum carbonate (LC) and calcium carbonate (CC) on vascular stiffness assessed using brachial-ankle pulse wave velocity (ba-PWV), intima-media thickness (IMT), bone mineral density (BMD), and serum markers of chronic kidney disease – mineral and bone disorder in such patients. Methods: Ba-PWV, IMT, BMD, and the biomarkers osteocalcin (OC) and bone alkaline phosphatase (BAP) were examined in 43 type 2 diabetes HD patients treated with LC (n=21) or CC (n=22) for 2 years. Results: Forty-one patients completed the study (19, LC; 22, CC). The mean ba-PWV significantly increased only in the CC group (median: 2,280.5 to 2,402.5 cm/s, P
AB - Background: Vascular calcification contributes to cardiovascular disease in hemodialysis (HD) patients with diabetes. The randomized controlled trial reported here compared the effects of lanthanum carbonate (LC) and calcium carbonate (CC) on vascular stiffness assessed using brachial-ankle pulse wave velocity (ba-PWV), intima-media thickness (IMT), bone mineral density (BMD), and serum markers of chronic kidney disease – mineral and bone disorder in such patients. Methods: Ba-PWV, IMT, BMD, and the biomarkers osteocalcin (OC) and bone alkaline phosphatase (BAP) were examined in 43 type 2 diabetes HD patients treated with LC (n=21) or CC (n=22) for 2 years. Results: Forty-one patients completed the study (19, LC; 22, CC). The mean ba-PWV significantly increased only in the CC group (median: 2,280.5 to 2,402.5 cm/s, P
KW - Diabetes
KW - Hemodialysis
KW - Lanthanum carbonate
KW - Randomized controlled trial
KW - Vascular stiffness
UR - http://www.scopus.com/inward/record.url?scp=84940539669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940539669&partnerID=8YFLogxK
U2 - 10.2147/IJNRD.S90791
DO - 10.2147/IJNRD.S90791
M3 - Article
AN - SCOPUS:84940539669
VL - 8
SP - 111
EP - 118
JO - International Journal of Nephrology and Renovascular Disease
JF - International Journal of Nephrology and Renovascular Disease
SN - 1178-7058
ER -